Skip to content

ATOSSA THERAPEUTICS, INC.

ATOS

CIK 0001488039

← back to feed
Revenue (TTM)
$0
−95.6% YoY Q1 May 2026
Net Income (TTM)
−$33.42M
−36.3% YoY Q1 May 2026
EPS Diluted (TTM)
−$2.03
−32.9% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
−$27.28M
Q1 May 2026
Cash
$31.72M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
8.61M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings